Physician profile
Paul Phillips
NPI 1215290580
$25,660.14
in general payments reported to CMS, 2019-2025
20 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $139 · 2021: $7,264 · 2022: $3,903 · 2023: $474 · 2024: $752 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.15 |
| Travel and Lodging | $431.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $10,867.00 | 2019-2022 | |
| Medinc of Texas | $5,933.00 | 2019 | |
| Arthrex, INC. | $5,680.87 | 2019-2024 | |
| Stryker Corporation | $1,530.40 | 2019-2024 | Inspace, Alphavent, Iconix |
| Smith+Nephew, INC. | $636.40 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Intuitive Surgical, INC. | $228.68 | 2019 | |
| Biocomposites INC | $157.66 | 2023 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $157.51 | 2022-2023 | Zilretta, Iovera, Exparel |
| Bioventus LLC | $93.44 | 2023-2025 | Xcell, Durolane, Stimrouter Implantable Kit |
| Medacta USA, INC. | $57.75 | 2021-2023 | Gmk Sphere |
| Depuy Synthes Sales INC. | $56.52 | 2019-2024 | Acis |
| Ucb, INC. | $54.05 | 2022 | |
| Kerecis Limited | $35.82 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Acera Surgical, INC. | $35.14 | 2025 | Restrata Wound Matrix |
| Janssen Pharmaceuticals, INC | $34.81 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $26.07 | 2025 | Urgok2 |
| Si-Bone, INC. | $24.96 | 2023 | |
| Vericel Corporation | $19.76 | 2025 | Maci |
| Pacira Therapeutics, INC. | $15.51 | 2020 | |
| Saluda Medical Americas, INC. | $14.79 | 2025 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.